Powering precision medicine for the brain
Beacon’s EEG neurobiomarker platform is engineered to accelerate clinical trials and enable new treatments for patients with neurological and psychiatric disease.
What We Do
- Efficacy
Quantitative assessment of treatment impact on EEG and ERP data ensure clinical endpoints are reached
- Safety Monitoring
EEG reports delivered with unprecedented speed and accuracy, eliminating adjudication with enhanced inclusion/exclusion criteria
- Population Stratification
Identify optimal patient populations to maximize effective treatments
Enabled by our end-to-end augmented EEG platform
State of the Art Machine Learning
World-Class Clinical EEG Database
Expert Neurologist Network
How We Create Impact
- Translational Research
Analyze existing EEG for insights into mechanism, PK/PD and patient stratification to guide further development efforts
- Clinical Trial Optimization
Improved cohort selection and proactive in-trial monitoring can mitigate risk of trial failure due to severe side effects or missed endpoints
- Commercial Differentiation
Best-in-class safety profiles and at-home monitoring are highly valued by both patients and clinicians
Trusted Partners & Investors
Partnerships
We partner with biopharma companies, academic medical centers, and neurotechnology developers to improve the diagnosis and treatment of neurological and psychiatric diseases.